Back to News
Market Impact: 0.2
Pulse Biosciences Reports Business Updates and Third Quarter 2026 Financial Results
Source: Nasdaq
Corporate EarningsCompany Fundamentals
Pulse Biosciences reported $189.2 million in cash, cash equivalents and marketable securities as of September 30, 2026, up from $101.6 million as of June 30, 2026. The provided article excerpt does not include further business updates or financial results.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
Ticker Sentiment
PLSE0.10
More News
- Pulse Biosciences reports interim thyroid nodule study results
- Further turmoil could be in store for tech stocks. What to watch in the week ahead
- Elon Musk once said the Cybertruck would be Tesla’s ‘best product ever.’ Now he’s winding down production
- AI stocks hammered by midterm shock as data center buildout becomes a 'war of attrition'
- Fox completes its $22B acquisition of Roku
- Elanco Shares Jump After Q3 Beat and Outlook Raise